145 related articles for article (PubMed ID: 24977159)
21. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
22. Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes.
Woodward ER; Clifford SC; Astuti D; Affara NA; Maher ER
J Med Genet; 2000 May; 37(5):348-53. PubMed ID: 10807693
[TBL] [Abstract][Full Text] [Related]
23. [Von-Hippel-Lindau gene mutation types. Association of gene expression signatures in clear cell renal cell carcinoma].
Luu VD; Fischer B; von Teichman A; Boysen G; Mertz K; Zimmermann P; Moch H; Schraml P
Pathologe; 2008 Nov; 29 Suppl 2():303-7. PubMed ID: 18751980
[TBL] [Abstract][Full Text] [Related]
24. Clear cell papillary renal cell carcinoma: a clinicopathological study emphasizing ultrastructural features and cytogenetic heterogeneity.
Shi SS; Shen Q; Xia QY; Tu P; Shi QL; Zhou XJ; Rao Q
Int J Clin Exp Pathol; 2013; 6(12):2936-42. PubMed ID: 24294381
[TBL] [Abstract][Full Text] [Related]
25. Genetic clustering of clear cell renal cell carcinoma based on array-comparative genomic hybridization: its association with DNA methylation alteration and patient outcome.
Arai E; Ushijima S; Tsuda H; Fujimoto H; Hosoda F; Shibata T; Kondo T; Imoto I; Inazawa J; Hirohashi S; Kanai Y
Clin Cancer Res; 2008 Sep; 14(17):5531-9. PubMed ID: 18765545
[TBL] [Abstract][Full Text] [Related]
26. Deletions of chromosomes 3p and 14q molecularly subclassify clear cell renal cell carcinoma.
Kroeger N; Klatte T; Chamie K; Rao PN; Birkhäuser FD; Sonn GA; Riss J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
Cancer; 2013 Apr; 119(8):1547-54. PubMed ID: 23335244
[TBL] [Abstract][Full Text] [Related]
27. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
28. Screening of epigenetic and genetic disturbances of human chromosome 3 genes in colorectal cancer.
Gerashchenko GV; Gordiyuk VV; Skrypkina IY; Kvasha SM; Kolesnik OO; Ugryn DD; Pavlova TV; Zabarovsky ER; Rynditch AV; Kashuba VI
Ukr Biokhim Zh (1999); 2009; 81(4):81-7. PubMed ID: 20387637
[TBL] [Abstract][Full Text] [Related]
29. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J
Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559
[TBL] [Abstract][Full Text] [Related]
30. Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis.
Dmitriev AA; Rosenberg EE; Krasnov GS; Gerashchenko GV; Gordiyuk VV; Pavlova TV; Kudryavtseva AV; Beniaminov AD; Belova AA; Bondarenko YN; Danilets RO; Glukhov AI; Kondratov AG; Alexeyenko A; Alekseev BY; Klein G; Senchenko VN; Kashuba VI
Dis Markers; 2015; 2015():241301. PubMed ID: 26491211
[TBL] [Abstract][Full Text] [Related]
31. Cytogenetic studies of 24 renal epithelial tumors with von Hippel-Lindau and fragile histidine triad protein expression correlation.
Gayrard N; Cacheux V; Iborra F; Mourad G; Argilés A
Arch Pathol Lab Med; 2008 Jun; 132(6):965-73. PubMed ID: 18517280
[TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array.
Toma MI; Grosser M; Herr A; Aust DE; Meye A; Hoefling C; Fuessel S; Wuttig D; Wirth MP; Baretton GB
Neoplasia; 2008 Jul; 10(7):634-42. PubMed ID: 18592004
[TBL] [Abstract][Full Text] [Related]
33. Alu-PCR approach to isolating NotI-linking clones from the 3p14-p21 region frequently deleted in renal cell carcinoma.
Zabarovsky ER; Kashuba VI; Pokrovskaya ES; Zabarovska VI; Wang JY; Berglund P; Boldog F; Stanbridge EJ; Sumegi J; Klein G
Genomics; 1993 Jun; 16(3):713-9. PubMed ID: 8325645
[TBL] [Abstract][Full Text] [Related]
34. Methylation pattern of the putative tumor-suppressor gene LRRC3B promoter in clear cell renal cell carcinomas.
Kondratov AG; Stoliar LA; Kvasha SM; Gordiyuk VV; Zgonnyk YM; Gerashchenko AV; Vozianov AF; Rynditch AV; Zabarovsky ER; Kashuba VI
Mol Med Rep; 2012 Feb; 5(2):509-12. PubMed ID: 22101383
[TBL] [Abstract][Full Text] [Related]
35. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
36. [Methylation of the genes for the microRNAs miR-129-2 and miR-9-1, changes in their expression, and activation of their potential target genes in clear cell renal cell carcinoma].
Pronina IV; Klimov EA; Burdennyy AM; Beresneva EV; Fridman MV; Ermilova VD; Kazubskaya TP; Karpukhin AV; Braga EA; Loginov VI
Mol Biol (Mosk); 2017; 51(1):73-84. PubMed ID: 28251969
[TBL] [Abstract][Full Text] [Related]
37. Tumor Suppressor Properties of Small C-Terminal Domain Phosphatases in Clear Cell Renal Cell Carcinoma.
Krasnov GS; Puzanov GA; Dashinimaev EB; Vishnyakova KS; Kondratieva TT; Chegodaev YS; Postnov AY; Senchenko VN; Yegorov YE
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629167
[TBL] [Abstract][Full Text] [Related]
38. Deregulation of PAX2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis.
Patrício P; Ramalho-Carvalho J; Costa-Pinheiro P; Almeida M; Barros-Silva JD; Vieira J; Dias PC; Lobo F; Oliveira J; Teixeira MR; Henrique R; Jeronimo C
J Cell Mol Med; 2013 Aug; 17(8):1048-58. PubMed ID: 23890189
[TBL] [Abstract][Full Text] [Related]
39. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic silencing of ASPP1 confers 5-FU resistance in clear cell renal cell carcinoma by preventing p53 activation.
Wang X; Cheng Y; Zhu Y; Li H; Ge W; Wu X; Zhao K; Yuan J; Li Z; Jiang S; Han Z; Jiang Q; Wu Q; Liu T; Zhang C; Yu M; Hu Y
Int J Cancer; 2017 Oct; 141(7):1422-1433. PubMed ID: 28656647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
